Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 28, 2020, titled "Glenmark to divest select Anti-Allergy brands to Dr Reddy s in Russia, Ukraine, Kazakhstan and Uzbekistan in anticipation of its Ryaltris Launch".